EARNEST Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-71
Closed -$15.1K 1155
2023
Q3
$15.1K Hold
71
﹤0.01% 547
2023
Q2
$13.7K Hold
71
﹤0.01% 562
2023
Q1
$14.4K Hold
71
﹤0.01% 543
2022
Q4
$9.12K Hold
71
﹤0.01% 638
2022
Q3
$10K Hold
71
﹤0.01% 599
2022
Q2
$13K Hold
71
﹤0.01% 553
2022
Q1
$10K Hold
71
﹤0.01% 669
2021
Q4
$11K Hold
71
﹤0.01% 662
2021
Q3
$12K Hold
71
﹤0.01% 616
2021
Q2
$11K Hold
71
﹤0.01% 641
2021
Q1
$10K Hold
71
﹤0.01% 646
2020
Q4
$12K Hold
71
﹤0.01% 578
2020
Q3
$14K Buy
71
+36
+103% +$6.03K ﹤0.01% 490
2020
Q2
$6K Hold
35
﹤0.01% 705
2020
Q1
$4K Hold
35
﹤0.01% 759
2019
Q4
$4K Hold
35
﹤0.01% 878
2019
Q3
$3K Hold
35
﹤0.01% 939
2019
Q2
$2K Hold
35
﹤0.01% 1045
2019
Q1
$3K Hold
35
﹤0.01% 954
2018
Q4
$2K Hold
35
﹤0.01% 1021
2018
Q3
$3K Hold
35
﹤0.01% 977
2018
Q2
$2K Hold
35
﹤0.01% 1070
2018
Q1
$2K Hold
35
﹤0.01% 1040
2017
Q4
$2K Buy
+35
New +$2.04K ﹤0.01% 1039
2017
Q1
Sell
-35
Closed -$2K 968
2016
Q4
$2K Buy
+35
New +$2.1K ﹤0.01% 984

Other funds holding SGEN

EARNEST Partners's SGEN Position: Q4 2023 in Review

EARNEST Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 71 shares — an estimated $15.1K sold.

EARNEST Partners first reported a position in SGEN in Q4 2016 and held it in 25 quarters. The position peaked at $15.1K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • EARNEST Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 71 Seagen Inc. Common Stock shares in Q4 2023, an estimated $15.1K.
  • EARNEST Partners first reported a position in Seagen Inc. Common Stock in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Seagen Inc. Common Stock position peaked at $15.1K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.